A critical breakthrough in cancer study is occurring with the use of mini-antibodies to re-engage mutated p53. This vital tumor inhibitor protein is frequently lost in several forms of cancer, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research